- Report
- June 2024
- 200 Pages
Global
From €7133EUR$7,950USD£6,140GBP
- Report
- January 2022
- 60 Pages
Global
From €3544EUR$3,950USD£3,050GBP
Aphasia is a language disorder that affects the ability to communicate. Aphasia drugs are used to treat this condition and are part of the Central Nervous System (CNS) drug market. These drugs are typically prescribed to improve language skills, such as speaking, understanding, reading, and writing. They can also help with memory and problem-solving. Commonly used aphasia drugs include anticonvulsants, antidepressants, and antipsychotics.
The CNS drug market is highly competitive, with many companies developing and marketing drugs for a variety of neurological conditions. Some of the major players in the aphasia drug market include Pfizer, Novartis, GlaxoSmithKline, and Merck. Other companies, such as Lundbeck, Sunovion, and Otsuka, are also active in the market. Show Less Read more